<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873364</url>
  </required_header>
  <id_info>
    <org_study_id>93-01-01-8312</org_study_id>
    <nct_id>NCT02873364</nct_id>
  </id_info>
  <brief_title>High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria</brief_title>
  <official_title>High Dose Vitamin D Supplementation in Treatment of Chronic Spontaneous Urticaria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic spontaneous urticaria is an inflammatory disease which is characterized with
      intermittent or daily urticaria. This diseases lasts for more than 6 weeks. Several recent
      studies have suggested a role for vitamin D in modulation of immune system and pathogenesis
      of chronic urticaria.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urticaria symptom severity questionnaire after 1 week</measure>
    <time_frame>1 weeks</time_frame>
    <description>Urticaria Symptom Severity ranging from 0 to 93</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urticaria symptom severity questionnaire after 6 week</measure>
    <time_frame>6 weeks</time_frame>
    <description>Urticaria Symptom Severity ranging from 0 to 93</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urticaria symptom severity questionnaire after 12 week</measure>
    <time_frame>12 weeks</time_frame>
    <description>Urticaria Symptom Severity ranging from 0 to 93</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Urticaria</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 (Low dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily 600 unites of vitamin D + Cetirizine 10mg twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D3 (High dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily 4000 unites vitamin D + Cetirizine 10mg twice a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3 (High dose)</intervention_name>
    <description>Daily 4000 unites vitamin D</description>
    <arm_group_label>Vitamin D3 (High dose)</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3 (Low dose)</intervention_name>
    <description>Daily 600 unites vitamin D</description>
    <arm_group_label>Vitamin D3 (Low dose)</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uriticaria or angioedema daily or more than 3 days a weeks for at least 6 weeks

        Exclusion Criteria:

          -  Physical urticaria aquired or hereditary angioedema Calcium level &gt; 10.3 mg/dl
             Glomerular filtration rate &lt;50 Sarcoidosis Primary hyperparathyroidism Granulomatous
             diseases Malignancies Pregnancy Lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keramatallah Jahanshahi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shiraz University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Keramatallah Jahanshahi, MD</last_name>
    <phone>+989177416523</phone>
    <email>kjahanshahi91@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shiraz University of Medical Sciences</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keramatallah Jahanshahi, MD</last_name>
      <phone>+989177416523</phone>
      <email>kjahanshahi91@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Keramatallah Jahanshahi</investigator_full_name>
    <investigator_title>Resident of internal medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urticaria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

